Wong RJ, et al. Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants. https://www.uptodate.com/contents/search. Accessed April 2, 2018.
Maisels MJ, et al. Hyperbilirubinemia in the newborn infant ≥35 weeks' gestation: An update with clarifications. Pediatrics. 2009;124:1193.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297.
Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. American Academy of Pediatrics. http://pediatrics.aappublications.org/content/114/1/297. Accessed April 2, 2018.
Hay WW, et al., eds. The newborn infant. In: Current Diagnosis & Treatment: Pediatrics. 23rd ed. New York, N.Y.: McGraw-Hill Education; 2016. https://www.accessmedicine.mhmedical.com. Accessed April 2, 2018.
Wong RJ, et al. Evaluation of unconjugated hyperbilirubinemia in term and late preterm infants. https://www.uptodate.com/contents/search. Accessed April 2, 2018.
Maisels MJ. Managing the jaundiced newborn: A persistent challenge. Canadian Medical Association Journal. 2015;187:335.
Muchowski KE. Evaluation and treatment of neonatal hyperbilirubinemia. American Family Physician. 2014;89:87.
Biliary atresia. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/liver-disease/biliary-atresia/all-content. Accessed Jan. 13, 2020.
Wong RJ. Unconjugated hyperbilirubinemia in the newborn: Pathogenesis and etiology.https://www.uptodate.com/contents/search. Accessed Feb. 5, 2020.
Picco MF (expert opinon). Mayo Clinic. Feb. 5, 2020.